Short communicationHuman recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease
Section snippets
Acknowledgements
This work was supported by NIH Grants (AG05131 and AG10689) and the Yamanouchi Pharmaceutical. We thank Drs. Leon Thal, Robert Katzman, and Makoto Yoshimoto for their continuous encouragement.
References (29)
- et al.
Peripheral nervous system-specific genes identified by subtractive cDNA cloning
J. Biol. Chem.
(1995) - et al.
Lewy bodies contain β-amyloid precursor proteins of Alzheimer's disease
Brain Res.
(1992) - et al.
Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. Analysis of circular dichroism spectra
J. Mol. Biol.
(1992) - et al.
Synuclein proteins and Alzheimer's disease
Trends Neurosci.
(1994) - et al.
Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
Neuron
(1995) - et al.
The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: is NAC a common trigger or target in neurodegenerative disease?
Chem. Biol.
(1995) - et al.
Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies
Neurosci. Lett.
(1991) - et al.
NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation
Biochem. Biophys. Res. Commun.
(1997) - et al.
Identification of two distinct synucleins from human brain
FEBS Lett.
(1994) - et al.
Seeding `one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?
Cell
(1993)
Evidence that the precursor protein of non-Ab component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil
Mol. Cells
(1997)
The rat brain synucleins; family of proteins transiently associated with neuronal membrane
Mol. Brain Res.
(1991)
Delayed localization of synelfin (synucleinm NACP) to presynaptic terminals in cultured rat hippocampal neurons
Dev. Brain Res.
(1997)
Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
Am. J. Pathol.
(1998)
Cited by (253)
Towards a biological diagnosis of PD
2024, Parkinsonism and Related DisordersIntermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
2022, Biophysical ChemistryIntracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction
2021, Neurobiology of AgingCitation Excerpt :Aggregated and phosphorylated states of αSyn are taken as markers of synucleinopathy. Preclinical rodent models of PD are generally accompanied with an increase of pS129 (Gorbatyuk et al. 2008; Wang et al. 2012), as well as indicators of aggregated αSyn, including proteinase-K (PK) resistance (Takeda et al. 1998), thioflavin S staining (Hashimoto et al. 1998), and presence in detergent-insoluble preparations (Campbell et al. 2000). In these models, the dopaminergic system is disrupted, and motor function is impaired.
Benzo(a)pyrene exposure in utero exacerbates Parkinson's Disease (PD)-like α-synucleinopathy in A53T human alpha-synuclein transgenic mice
2021, Toxicology and Applied PharmacologyAn α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3
2021, Journal of Biological Chemistry
Copyright © 1998 Published by Elsevier B.V.